Confocal observation (Fig. 4d), as well as statistical analysis (Fig. 4e) consistently confirm gradual increases of TIPRL, LC3 and CD133 levels according to liver cancer progression, suggesting critical roles of TIPRL, LC3 and CD133 association in the progression of liver cancers. This evidence concerns the gene MAP1LC3A and liver cancer.